Physician profile
Sreenivasa Basavanthappa
NPI 1497953871
$4,648.66
in general payments reported to CMS, 2019-2025
22 companies · $570 in 2025
The $570 reported for 2025 was more than what a typical Retina Specialist provider received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,959 · 2020: $94.04 · 2021: $348 · 2022: $502 · 2023: $501 · 2024: $676 · 2025: $570.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,747.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,746.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thrombogenics, INC. | $1,500.00 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $571.38 | 2020-2025 | Eylea Hd, Eylea |
| Abbvie INC. | $532.16 | 2022-2025 | Ozurdex |
| Astellas Pharma US INC | $450.69 | 2023-2025 | Izervay |
| Genentech USA, INC. | $403.19 | 2020-2025 | Vabysmo |
| Apellis Pharmaceuticals, INC. | $240.36 | 2022-2025 | Syfovre |
| Carl Zeiss Meditec, INC. | $229.12 | 2019-2020 | |
| Biogen, INC. | $155.62 | 2022-2024 | Byooviz |
| Hoffmann-La Roche Limited | $140.40 | 2019 | |
| Allergan, INC. | $89.72 | 2019-2021 | |
| Ani Pharmaceuticals, INC. | $66.82 | 2022 | |
| Carl Zeiss Meditec USA, INC. | $57.59 | 2021 | |
| Novartis Pharmaceuticals Corporation | $38.40 | 2020-2021 | |
| Coherus Oncology, INC. | $27.91 | 2022 | |
| Genentech, INC. | $24.50 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $23.15 | 2022 | |
| Bausch & Lomb Americas INC. | $20.92 | 2022 | |
| Spark Therapeutics, INC. | $20.46 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $15.88 | 2019 | |
| Alcon Vision LLC | $14.50 | 2019 | |
| Aerie Pharmaceuticals, INC. | $14.17 | 2019 | |
| Alimera Sciences, INC. | $11.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sreenivasa Basavanthappa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.